|
|
|
Volumn 32, Issue 13, 2005, Pages 2035-2039
|
|
The role of taxanes for head and neck cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOCETAXEL;
FLUOROURACIL;
TAXOID;
CHEMICALLY INDUCED DISORDER;
DRUG ADMINISTRATION;
HEAD AND NECK TUMOR;
HUMAN;
MULTIMODALITY CANCER THERAPY;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
SQUAMOUS CELL CARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
NEUTROPENIA;
TAXOIDS;
|
|
EID: 33644681904
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (15)
|
